Bubs signs major deal with leading Chinese e-commerce platform

Bubs signs major deal with leading Chinese e-commerce platform

Bubs Australia (ASX: BUB) has partnered with leading Chinese e-commerce platform Alibaba to sell its products on the Tmall Global store.

Alibaba has 580 million monthly users across its different apps, with mother and baby products the second largest category on Alibaba, spearheaded by infant formula.

Bubs expects the Global Merchandise Value to be in excess of approximately $1 million in the first year of trading.

This is a major deal for the Australian infant milk formula producer and is expected to give them a larger footprint in China, according to founding managing director of Bubs Australia Kristy Carr.

"Alibaba is one of the largest retailers in the world," says Carr.

"This is therefore an important milestone in the evolution of our cross-border e-commerce strategy that will significantly broaden our reach to Chinese parents."

Carr says the group's unique market position and product offering will be a massive advantage when competing on the Chinese platform.

"As the only Australian vertically integrated producer of goat milk infant formula, we will be in a unique position to offer Chinese parents comfort that we have complete control over the quality and scalability of our supply chain back to the farm gate," says Carr.

"With this solid foundation in place, and with the support of the Alibaba team, we believe we are well positioned to establish a popular Flagship Store on Tmall Global."

The company has also made a significant step toward getting its product ready for the Chinese market after entering into a deal with Australia Deloraine Dairy (ADD).

ADD is one of only 15 licenced facilities in Australia authorised by Certification and Accreditation Administration of the People's Republic of China to produce infant formula products eligible for importation into China.

Bubs Australia chairman Dennis Lin says this is an important step to getting its products into China.

"This strategic partnership is a crucial step in achieving China Food and Drug Administration (CFDA) registration, enabling us to advance our China expansion strategy," says Lin.

"There is an increasing demand for goat milk based infant formula in China, especially in Mother and Baby stores. The Manufacturing Agreement will facilitate our CFDA registration and provide a defined pathway to maximising Bubs' access to 80,000 stores aligned with our partner QuanJaiWanPu, China's largest nationwide distributor of infant formula."

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Subscribe Now!
Four time-saving tips for automating your investment portfolio
Partner Content
In today's fast-paced investment landscape, time is a valuable commodity. Fortunately, w...
Etoro
Advertisement

Related Stories

HMC Capital enters private credit market with $127.5m purchase of Payton Capital

HMC Capital enters private credit market with $127.5m purchase of Payton Capital

After more than a year of due diligence and amidst plans to lift it...

Cost of living elevates salaries and perks as key drivers of employee retention in 2024

Cost of living elevates salaries and perks as key drivers of employee retention in 2024

The cost of living is making salaries and perks just as important a...

Enterprise roll-out "one of the biggest launches in Canva's history" as ARR hits $2.2b

Enterprise roll-out "one of the biggest launches in Canva's history" as ARR hits $2.2b

Sydney-headquartered graphic design and visualisation tool giant Ca...

The Star unsuitable to hold a casino licence, final Bell Inquiry submissions claim

The Star unsuitable to hold a casino licence, final Bell Inquiry submissions claim

The Star Entertainment Group (ASX: SGR) has been declared unsuitabl...